The SIRSVIDE model developed by Professor Jian Lu's research group provides a comprehensive framework for studying viral epidemiology and evolutionary dynamics. The simulation results reveal that ...

The influenza (flu) virus is constantly undergoing a process of evolution and adaptation through acquiring new mutations. Scientists at St. Jude Children's Research Hospital have added a new layer of ...

Understanding the mutation and evolution of viruses (such as SARS-CoV-2) is crucial for effective public health management and response. Traditional epidemiological models often assume that viral ...

A Rowan University team led by Chun Wu, Ph.D., received the Zuckerkandl Prize for the year’s best paper published in the ...

Drugs are potent weapons against viral pathogens. During the early stages of the COVID-19 pandemic, there were intensive efforts to discover and implement antiviral drugs that could treat SARS-CoV-2 ...

The core breakthroughs of the new generation of RNA virus detection technologies focus primarily on two key objectives: first, enhancing biosensor mutation tolerance-specifically, developing sensors ...

Vaccinating birds against bird flu reduces the spread of the disease, but may have unintended consequences. This is the warning of a new paper in the journal Science Advances, which concluded that ...

The study, published in the Biophysical Journal, was led by a team of researchers from the Science and Technology Facilities Council’s (STFC) Hartree Centre and IBM, at the Hartree National Centre for ...

The collaborative efforts of researchers at Harvard and Oxford have yielded an artificial intelligence tool known as EVEscape. This tool is comprised of two key components: a sequence model that ...

Chinese researchers have unveiled a crucial mutation in the Ebola virus that significantly enhanced its infectivity during a major outbreak, providing new insights for epidemic surveillance and drug ...

There are currently two approved COVID-19 treatments that can be taken orally: nirmatrelvir-ritonavir (known as Paxlovid and developed by Pfizer) and Merck’s molnupiravir. They have both been shown to ...